April 2026 FDA Updates: Compounding, Atinvicitinib & GFI #273 | ACVP
April 2026 Regulatory Roundup: FDA Compounding, New Approvals, and Stewardship Erica Wassack, PharmD, DICVP, FACVP Regulatory & Governmental Affairs Liaison The following updates summarize recent FDA activity relevant to pharmacy and veterinary practice. Please review and share with your team as appropriate. FDA Compounding Listening Session — February 27, 2026 The FDA hosted a formal [...]